Autopulse Resuscitation System
510(k) K022345
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK022345 | Date15 Aug 2002 | StatusActive |
Recalls
-
- Terminated Z-2090-2014
Typographical error in the Japanese legal label of the AutoPulse Resuscitation System Model 100. The label is specific to the Japanese version of the product.
-
- Terminated Z-0658-2013
Complaints associated with an unexpected stop in AutoPulse compressions.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DRM
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.5200
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The AutoPulse Resuscitation System Model 100 is an external cardiac compressor designed to deliver controlled, high-quality chest compressions during cardiopulmonary resuscitation (CPR). Classified as a Class II device under FDA regulations, it is intended to assist in maintaining circulation when manual CPR is impractical or insufficient, particularly in emergency settings where sustained, consistent compression is critical.
This system is supplied as a reusable medical device, intended for use in pre-hospital, emergency department, and critical care environments. It operates with Revivant Corp.-approved accessories and requires no additional battery (as noted in the manual context), though storage and maintenance follow manufacturer guidelines to ensure proper functionality. The device is regulated under FDA 510(k) clearance (K022345) and adheres to compliance standards for external cardiac compressors, including MRI safety considerations where applicable.
Other devices from Revivant Corp.
Questions
AI-generated answers, 19 Sep 2026
What environments is the AutoPulse Resuscitation System designed for, and how does its reusable nature impact its use?
The AutoPulse Resuscitation System is specifically designed for pre-hospital settings, emergency departments, and critical care environments where sustained, consistent chest compressions are critical during CPR. Since it is a reusable device, it requires strict adherence to Revivant Corp.’s storage and maintenance guidelines to ensure reliability and functionality over repeated uses. This makes it ideal for high-traffic or long-term clinical settings where single-use alternatives may not be practical.
Does the AutoPulse Resuscitation System require any additional power source, and if not, how is it powered?
The AutoPulse Resuscitation System does not require an additional battery, as noted in its manual context. Instead, it operates using its own integrated power source, which is designed to deliver consistent compressions during CPR. However, proper storage and maintenance are essential to ensure the device remains operational for emergency use.
What regulatory pathway was followed for the FDA clearance of the AutoPulse Resuscitation System, and what does this mean for its use?
The AutoPulse Resuscitation System was cleared through the FDA’s 510(k) pathway, specifically under clearance number K022345, with a decision date of August 15, 2002. This classification as a Class II device and the special 510(k) clearance route indicate that it has been deemed substantially equivalent to a legally marketed predicate device, ensuring it meets FDA standards for external cardiac compressors while adhering to compliance requirements, including MRI safety considerations where applicable.
Are there multiple models or sizes available for the AutoPulse Resuscitation System, and how would a buyer determine the correct fit for their needs?
The provided data does not specify multiple models or sizes for the AutoPulse Resuscitation System, but it is classified under product code DRM (Defibrillator/Resuscitator Modules) and is intended for general use in cardiac resuscitation. Buyers should consult Revivant Corp.’s technical specifications or contact their support team to confirm compatibility with their specific clinical or pre-hospital requirements, such as patient size ranges or environmental conditions.